Comparing changes in haematologic parameters occurring in patients included in randomized controlled trials of artesunate-amodiaquine vs single and combination treatments of uncomplicated falciparum in sub-Saharan Africa

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Zwang, Julien ^a   Ndiaye, Jean Louis ^b   Djimdé, Abdoulaye ^c   Dorsey, Grant ^d   Mårtensson, Andreas ^e,f   Karema, Corine ^g   Olliaro, Piero ^h,i  

^a Drugs for Neglected Diseases initiative DNDi   (Switzerland)

^b UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^c UNIVERSITY OF BAMAKO   (Mali)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f KAROLINSKA INSTITUTE   (Sweden)

^g MINISTÈRE DE LA SANTÉ   (Burkina Faso)

^h WORLD HEALTH ORGANIZATION   (Switzerland)

ⁱ UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Amodiaquine; Artesunate; Haematology; Plasmodium falciparum; Randomized controlled trial; Sub Saharan Africa

Indexed keywords

AMODIAQUINE; AMODIAQUINE PLUS ARTESUNATE; ARTEMISININ; ARTESUNATE; BENFLUMETOL; COARSUCAM; DIHYDROARTEMISININ; FLAVOQUIN; HEMOGLOBIN; PYRIMETHAMINE; SULFADOXINE; UNCLASSIFIED DRUG; AMODIAQUINE, ARTESUNATE DRUG COMBINATION; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE;

AFRICA SOUTH OF THE SAHARA; ANEMIA; ARTICLE; DISEASE SEVERITY; DRUG SAFETY; EVALUATION AND FOLLOW UP; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HUMAN; LEUKOCYTE COUNT; LEUKOPENIA; MALARIA FALCIPARUM; NEUTROPENIA; NEUTROPHIL COUNT; PARASITEMIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SINGLE DRUG DOSE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; ADOLESCENT; ADULT; AGED; BLOOD ANALYSIS; BLOOD CELL; CHILD; COMPARATIVE STUDY; DRUG COMBINATION; DRUG EFFECT; FEMALE; INFANT; MALE; MIDDLE AGED; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; AGED; AMODIAQUINE; ANTIMALARIALS; ARTEMISININS; BLOOD CELLS; BLOOD CHEMICAL ANALYSIS; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; YOUNG ADULT;

EID: 84856106560     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-25     Document Type: Article

References (25)

1. World Health Organization, Guidelines for the treatment of malaria Second 2010 http://whqlibdoc.who.int/publications/2010/9789241547925-eng.pdf Accessed 4/4/2011
2. Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain. Phillips-Howard PA, West LJ, J R Soc Med 1990 83 82 85 2138674 (Pubitemid 20159350)
3. Systematic review of amodiaquine treatment in uncomplicated malaria. Olliaro P, Nevill C, LeBras J, Ringwald P, Mussano P, Garner P, Brasseur P, Lancet 1996 348 1196 1201 10.1016/S0140-6736(96)06217-4 8898036 (Pubitemid 26361606)
4. Artemisinin-based combination therapy for treating uncomplicated malaria. Sinclair D, Zani B, Donegan S, Olliaro P, Garner P, Cochrane Database Syst Rev 2009 8 D007483 Review
5. Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparu malaria in African children: a randomised, multicentre trial. Adjuik M, Agnamey P, Babiker A, Borrmann S, Brasseur P, Cisse M, Cobelens F, Diallo S, Faucher JF, Garner P, Gikunda S, Kremsner PG, Krishna S, Lell B, Loolpapit M, Matsiegui PB, Missinou MA, Mwanza J, Ntoumi F, Olliaro P, Osimbo P, Rezbach P, Some E, Taylor WR, Lancet 2002 359 1365 1372 10.1016/S0140-6736(02)08348-4 11978332 (Pubitemid 34442375)
6. The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparu. Sirima SB, Tiono AB, Gansane A, Diarra A, Ouedraogo A, Konate AT, Kiechel JR, Morgan CC, Olliaro PL, Taylor WR, Malar J 2009 8 48 10.1186/1475-2875-8-48 19291301
7. High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda. Gasasira AF, Kamya MR, Achan J, Mebrahtu T, Kalyango JN, Ruel T, Charlebois E, Staedke SG, Kekitiinwa A, Rosenthal PJ, Havlir D, Dorsey G, Clin Infect Dis 2008 46 985 991 10.1086/529192 18444813 (Pubitemid 351589861)
8. Disease and drug interactions: treating malaria with artesunate plus amodiaquine in patients also receiving treatment for concomitant HIV infection. Olliaro P, Clin Infect Dis 2008 46 992 993 10.1086/529193 18444814 (Pubitemid 351589862)
9. Dose-dependent risk of neutropenia after 7-day courses of artesunate monotherapy in Cambodian patients with acute Plasmodium falciparu malaria. Bethell D, Se Y, Lon C, Socheat D, Saunders D, Teja-Isavadharm P, Khemawoot P, Darapiseth S, Lin J, Sriwichai S, Kuntawungin W, Surasri S, Lee SJ, Sarim S, Tyner S, Smith B, Fukuda MM, Clin Infect Dis 2010 51 105 114 10.1086/657402
10. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparu malaria in Zanzibar, Tanzania. Martensson A, Stromberg J, Sisowath C, Msellem MI, Gil JP, Montgomery SM, Olliaro P, Ali AS, Björkman A, Clin Infect Dis 2005 41 1079 1086 10.1086/444460 16163624 (Pubitemid 41429468)
11. Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up. Adjei GO, Kurtzhals JA, Rodrigues OP, Alifrangis M, Hoegberg LC, Kitcher ED, Badoe EV, Lamptey R, Goka BQ, Malar J 2008 7 127 10.1186/1475-2875-7-127 18620577 (Pubitemid 352033070)
12. Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis. Zwang J, Olliaro P, Barennes H, Bonnet M, Brasseur P, Bukirwa H, Cohuet S, D'Alessandro U, Djimdé A, Karema C, Guthmann JP, Hamour S, Ndiaye JL, Mårtensson A, Rwagacondo C, Sagara I, Same-Ekobo A, Sirima SB, van den Broek I, Yeka A, Taylor WR, Dorsey G, Randrianarivelojosia M, Malar J 2009 8 203 10.1186/1475-2875-8-203 19698172
13. Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali. Djimdé AA, Fofana B, Sagara I, Sidibe B, Toure S, Dembele D, Dama S, Ouologuem D, Dicko A, Doumbo OK, Am J Trop Med Hyg 2008 78 455 461 18337343 (Pubitemid 351845197)
14. Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. Dorsey G, Staedke S, Clark TD, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, Dokomajilar C, Kamya MR, Rosenthal PJ, JAMA 2007 297 2210 2219 10.1001/jama.297.20.2210 17519410
15. Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparu malaria in Rwandan children. Karema C, Fanello CI, van Overmeir C, van Geertruyden JP, van Doren W, Ngamije D, D'Alessandro U, Trans R Soc Trop Med Hyg 2006 100 1105 1111 10.1016/j.trstmh.2006.01.001 16766006 (Pubitemid 44464010)
16. Randomized, multicentre assessment of the efficacy and safety of ASAQ-a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparu malaria. Ndiaye JL, Randrianarivelojosia M, Sagara I, Brasseur P, Ndiaye I, Faye B, Randrianasolo L, Ratsimbasoa A, Forlemu D, Moor VA, Traore A, Niawanlou Dara YD, Lameyre V, Diallo M, Djimde A, Same-Ekobo A, Gaye O, Malar J 2009 8 125 10.1186/1475-2875-8-125 19505304
17. Is amodiaquine failing in Rwanda? Efficacy of amodiaquine alone and combined with artesunate in children with uncomplicated malaria. Rwagacondo CE, Karema C, Mugisha V, Erhart A, Dujardin JC, Van Overmeir C, Ringwald P, D'Alessandro U, Trop Med Int Health 2004 9 1091 1098 10.1111/j.1365-3156.2004. 01316.x 15482401 (Pubitemid 39423087)
18. Common Toxicity Criteria-Version 2, National Cancer Institute, USA
19. Division of Microbiology and Infectious Diseases Pediatric Toxicity Tables. NIAID, 2007 http://www.niaid.nih.gov Accessed June 2011
20. The relationship between the haemoglobin concentration and the haematocrit in Plasmodium falciparu malaria. Lee SJ, Stepniewska K, Anstey N, Ashley E, Barnes K, Binh TQ, D'Alessandro U, Day NP, de Vries PJ, Dorsey G, Guthmann JP, Mayxay M, Newton P, Nosten F, Olliaro P, Osario L, Pinoges L, Price R, Rowland M, Smithuis F, Taylor R, White NJ, Malar J 2008 7 149 10.1186/1475-2875-7-149 18673575
21. The lagrange multiplier test and its applications to model specification in econometrics. Breusch TS, Pagan AR, Rev Econ Stud 1980 47 239 253 10.2307/2297111
22. Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children. Maiteki-Sebuguzi C, Jagannathan P, Yau VM, Clark TD, Njama-Meya D, Nzarubara B, Talisuna AO, Kamya MR, Rosenthal PJ, Dorsey G, Staedke SG, Malar J 2008 7 106 10.1186/1475-2875-7- 106 18547415 (Pubitemid 351904896)
23. Efficacy and tolerability of artesunate-amodiaquine (Camoquin plus) versus artemether-lumefantrine (Coartem) against uncomplicated Plasmodium falciparu malaria: multisite trial in Senegal and Ivory Coast. Faye B, Offianan AT, Ndiaye JL, Tine RC, Touré W, Djoman K, Sylla K, Ndiaye PS, Penali L, Gaye O, Trop Med Int Health 2010 15 608 613 20214761
24. Haematological in paediatric uncomplicated falciparum malaria in Sub-Saharan Africa. Olliaro P, Djimdé A, Dorsey G, Karema C, Mårtensson A, Ndiaye JL, Sirima SB, Vaillant M, Zwang J, Am J Trop Med Hyg 2011 85 619 625 10.4269/ajtmh.2011.11-0154 21976561
25. Artesunate and artelinic acid: association of embryotoxicity, reticulocytopenia, and delayed stimulation of hematopoiesis in pregnant rats. Clark RL, Brannen KC, Sanders JE, Hoberman AM, Birth Defects Res B Dev Reprod Toxicol 2011 92 52 68 10.1002/bdrb.20282 21312322